Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1691-1700 of 9365

Page
per page
  1. Rostafuroxin (PST 2238)
    B5894 Rostafuroxin (PST 2238)
    Summary: Na+/K+ ATPase modulator
      insoluble in H2O; insoluble in EtOH; ≥12.05 mg/mL
  2. CARIPORIDE
    B5895 CARIPORIDE
    Target: NHE
    Summary: Potent NHE inhibitor
      insoluble in H2O; ≥12.05 mg/mL
  3. VRT-1353385
    B5896 VRT-1353385
    Summary: antibiotic compound
      insoluble in EtOH; insoluble in H2O; ≥20.2 mg/mL
  4. K-7174
    B5898 K-7174
    Summary: Orally active proteasome inhibitor
      ≥64.2 mg/mL
  5. CL-387785 (EKI-785)
    B5899 CL-387785 (EKI-785)
    Summary: Irreversible inhibiter of EGFR
      insoluble in EtOH; insoluble in H2O; ≥16.85 mg/mL
  6. LED209
    B5902 LED209
    Summary: Highly selective for histidine sensor kinase QseC
      insoluble in EtOH; insoluble in H2O; insoluble in DMSO
  7. Regadenoson
    B5904 Regadenoson
     1 Citation
    Target: Adenosine A2A Receptors
    Summary: Highly selective and low affinity A2A adenosine agonist
      insoluble in H2O; insoluble in EtOH; ≥18.05 mg/mL
  8. Tiplaxtinin(PAI-039)
    B5906 Tiplaxtinin(PAI-039)
    Summary: Orally efficacious inhibitor of PAI-1
      insoluble in H2O; ≥17.6 mg/mL
  9. SBC-115076
    B5907 SBC-115076
    Summary: Anti-PCSK9 compound
      ≥52.8 mg/mL
  10. Rolapitant HCl
    B5910 Rolapitant HCl
    Target: NK1 Receptors
    Summary: Orally active neurokinin NK1 receptor antagonist.

Items 1691-1700 of 9365

Page
per page